Authors: Sepp-Lorenzino, L Tjaden, G Moasser, MM Timaul, N Ma, Z Kohl, NE Gibbs, JB Oliff, A Rosen, N Scher, HI

Citation: L. Sepp-lorenzino et al., Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer, PROSTATE C, 4(1), 2001, pp. 33-43

Authors: Van Poznak, C Seidman, AD Reidenberg, MM Moasser, MM Sklarin, N Van Zee, K Borgen, P Gollub, M Bacotti, D Yao, TJ Bloch, R Ligueros, M Sonenberg, M Norton, L Hudis, C

Citation: C. Van Poznak et al., Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial, BREAST CANC, 66(3), 2001, pp. 239-248

Authors: Munster, PN Srethapakdi, M Moasser, MM Rosen, N

Citation: Pn. Munster et al., Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells, CANCER RES, 61(7), 2001, pp. 2945-2952

Authors: Moasser, MM Basso, A Averbuch, SD Rosen, N

Citation: Mm. Moasser et al., The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells, CANCER RES, 61(19), 2001, pp. 7184-7188

Authors: Moasser, MM Srethapakdi, M Sachar, KS Kraker, AJ Rosen, N

Citation: Mm. Moasser et al., Inhibition of src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest, CANCER RES, 59(24), 1999, pp. 6145-6152